Purpose
to develop a novel anti-Wolbachia (A-WOL) based macrofilaricidal drug for the treatment of onchocerciasis and lymphatic filariasis that is capable of achieving clinical cure within a specified dosage regimen
Grantee
Division
Global Health
Date
OCTOBER 2012
Region served
GLOBAL
Committed amount
$9,789,259
Grant topic
Neglected Tropical Diseases
Duration (months)
69
Grantee location
Liverpool, United Kingdom
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.